CCL2 gene homepage

General information
Gene symbol CCL2
Gene name chemokine (C-C motif) ligand 2
Chromosome 17
Chromosomal band q11.2-q21.1
Imprinted Unknown
Genomic reference NG_012123.1
Transcript reference NM_002982.3
Associated with diseases NTD, Mycobacterium tuberculosis, susceptibility to, virus, human immunodeficiency, susceptibility to
Citation reference(s) -
Curators (1) LOVD-team, but with Curator vacancy
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created May 03, 2013

Links to other resources
HGNC 10618
Entrez Gene 6347
PubMed articles CCL2
OMIM - Gene 158105
OMIM - Diseases NTD (neural tube defects, incl. spina bifida (NTD))
Mycobacterium tuberculosis, susceptibility to
virus, human immunodeficiency, susceptibility to

Active transcripts




NCBI ID     

NCBI Protein ID     

00004589 17 chemokine (C-C motif) ligand 2 NM_002982.3 NP_002973.1 0

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2013-2019. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.